Torres Mylin A, Yang Xiaofeng, Noreen Samantha, Chen Hao, Han Tatiana, Henry Simone, Mister Donna, Andic Fundagal, Long Qi, Liu Tian
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia; Winship Cancer Institute, Emory University, Atlanta, Georgia.
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia; Winship Cancer Institute, Emory University, Atlanta, Georgia.
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):590-6. doi: 10.1016/j.ijrobp.2016.01.030. Epub 2016 Jan 23.
This prospective study was conducted to determine predictors of epidermal thickening during and after whole-breast radiation therapy (XRT) using objective measurements acquired with ultrasound.
After breast-conserving surgery, 70 women received a definitive course of whole-breast XRT (50 Gy plus boost). Prior to XRT, at week 6 of XRT, and 6 weeks after XRT, patients underwent objective ultrasound measurements of epidermal thickness over the lumpectomy cavity and all 4 quadrants of the treated breast. A skin thickness ratio (STRA) was then generated normalizing for corresponding measurements taken of the untreated breast.
Baseline measurements indicated that 87% of patients had skin thickening in the treated versus untreated breast (mean increase, 27%; SD, 0.29) prior to XRT. The STRA increased significantly by week 6 of XRT (mean, 25%; SD, 0.46) and continued to increase significantly 6 weeks after XRT (mean, 33%; SD, 0.46) above baseline measurements (P<.001 for both time points). On multivariate analysis, breast volume (P=.003) and surgical evaluation of the axilla with full lymph node dissection (P<.05) predicted for more severe changes in the STRA 6 weeks after XRT compared with baseline. STRA measurements correlated with physician ratings of skin toxicity according to Radiation Therapy Oncology Group grading criteria.
This is one of the first studies to objectively document that lymph node surgery affects XRT-induced skin thickening in patients with breast cancer. Surgical evaluation of the axilla with complete lymph node dissection was associated with the most severe XRT-induced skin changes after XRT completion. These results may inform future studies aimed at minimizing side effects of XRT and surgery, particularly when surgical lymph node assessments may not alter breast cancer management or outcome.
本前瞻性研究旨在通过超声客观测量来确定全乳放疗(XRT)期间及之后表皮增厚的预测因素。
70名女性在保乳手术后接受了全乳XRT的标准疗程(50 Gy加局部加量)。在XRT之前、XRT第6周以及XRT后6周,患者接受了对乳房切除腔及治疗侧乳房所有4个象限的表皮厚度的客观超声测量。然后生成皮肤厚度比(STRA),对未治疗侧乳房的相应测量值进行标准化。
基线测量表明,87%的患者在XRT之前,治疗侧乳房与未治疗侧乳房相比存在皮肤增厚(平均增加27%;标准差,0.29)。STRA在XRT第6周时显著增加(平均,25%;标准差,0.46),并且在XRT后6周继续显著高于基线测量值(平均,33%;标准差,0.46)(两个时间点P均<.001)。多因素分析显示,与基线相比,乳房体积(P=.003)和腋窝手术伴完全淋巴结清扫(P<.05)预测XRT后6周STRA变化更严重。根据放射治疗肿瘤学组分级标准,STRA测量值与医生对皮肤毒性的评分相关。
这是首批客观记录淋巴结手术会影响乳腺癌患者XRT诱导的皮肤增厚的研究之一。腋窝手术伴完全淋巴结清扫与XRT完成后最严重的XRT诱导的皮肤变化相关。这些结果可能为未来旨在最小化XRT和手术副作用的研究提供信息,特别是当手术淋巴结评估可能不会改变乳腺癌治疗或结果时。